sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 851-875 out of 1343.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 > >>

Public Release: 7-Dec-2015
UK and Chinese scientists join forces to combat city pollution
New research into toxic fumes polluting a Chinese megacity could help protect the health of millions in the coming decades.
Natural Environment Research Council

Contact: Mary Goodchild
Natural Environment Research Council

Public Release: 3-Dec-2015
New funding for Ebola hides an ongoing decline
A new report gives the first ever picture of global investment in Ebola R&D, reporting that this investment might have come at the expense of efforts to develop health technologies for other neglected diseases. The report found that $3.4 billion was invested in neglected disease R&D in 2014. New funding for Ebola R&D was entirely responsible for the $150 million increase in neglected disease R&D funding in 2014, with funding for all other neglected diseases down 0.4 percent.
Bill & Melinda Gates Foundation

Contact: Lisette Oversteegen
PATH - Global Health Technologies Coalition

Public Release: 2-Dec-2015
Little known about children living with HIV-infected adults in Africa
Despite the focus in recent decades on fighting the HIV/AIDS epidemic in Sub-Saharan Africa, a new study reveals that little is known about one of the area's most vulnerable populations: children living in households with HIV-infected adults.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

Contact: Courtney Coelho
Brown University

Public Release: 2-Dec-2015
Concern over drug industry involvement at India's 'health camps'
Pharmaceutical sales representatives are screening people in India in return for prescriptions for their products, finds a special report published by The BMJ today.

Contact: Emma Dickinson

Public Release: 1-Dec-2015
World AIDS Day 2015: Study begins in Kenya for recently-approved pediatric HIV treatment
DNDi has begun an implementation study of a recently-approved pediatric antiretroviral (ARV) treatment in order to address the urgent need for better medicines for children living with HIV. This study, which has begun in Kenya, is an important step towards DNDi's ultimate goal of developing, together with the Indian generic pharmaceutical company Cipla Ltd and in partnership with UNITAID, improved and easy-to-take combinations of the key HIV medicines children need to survive into adulthood.

Contact: Ilan Moss
Drugs for Neglected Diseases Initiative

Public Release: 1-Dec-2015
Free new tool for health providers to manage symptoms of AIDS
Millions of people are now living with -- rather than dying from -- HIV in Sub-Saharan Africa due to combination drug therapies. But the vast majority struggle to manage the many disabilities caused by this disease and its treatment. Today, University of Toronto researchers and their partners in Zambia, Kenya, South Africa and Canada launched a free website to help health workers improve the quality of life of adults and children living with HIV throughout Africa.

Contact: Heidi Singer
University of Toronto

Public Release: 30-Nov-2015
Vector-Borne and Zoonotic Diseases
Study: With climate change, malaria risk in Africa shifts, grows
A larger portion of Africa is currently at high risk for malaria transmission than previously predicted, according to a new University of Florida mapping study.

Contact: Sadie Ryan
University of Florida

Public Release: 26-Nov-2015
Recommended activity levels not achieved by obese children and those with liver disease
In a new study published today in the journal Nutrients, research from the University of Surrey and the Children's Liver Disease Foundation has found that both obese children and those with non-alcoholic fatty liver disease are not meeting the UK recommendations for a variety of vitamins and minerals.

Contact: Peter La
University of Surrey

Public Release: 26-Nov-2015
BMJ Open
More than 1 in 4 older Indians on low and middling incomes have midriff bulge
More than one in four middle-aged Indians on low and middling incomes now has an unhealthy midriff bulge, with women most likely to carry a spare tire, reveal the results of a nationally representative survey, published in the online journal BMJ Open.

Contact: Caroline White

Public Release: 26-Nov-2015
Researchers uncover essential interaction between malaria parasites and liver cells
Scientists at the Center for Infectious Disease Research recently uncovered a critical piece in the puzzle of how malaria parasites infect their host. The work, recently published in Science Magazine, reveals the details of how the malaria parasite invades its initial target organ, the liver. Without infection of the liver, the parasites cannot multiply or spread to the blood. Infection of the blood causes illness, spread of the disease, and, ultimately, death.

Contact: Morgan Clary
The Center for Infectious Disease Research

Public Release: 25-Nov-2015
Antimicrobial Agents and Chemotherapy
Population Council's MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study
New data from a preclinical safety and efficacy study of the candidate microbicide gel MZC, which targets HIV, herpes simplex virus and human papillomavirus, shows that the gel performs as well as, or in many cases, better than, tenofovir 1 percent gel, a leading microbicide candidate.

Contact: Jennifer Brunet
Population Council

Public Release: 25-Nov-2015
American Journal of Nursing
As 2nd anniversary nears of Ebola breakout in West Africa, nurse provides firsthand account of combating Ebola
International nurse volunteers responding to the Ebola outbreak in West African encountered death on nearly every shift and worked under conditions that challenged their ingenuity in providing even basic care. That is according to one nurse's account in American Journal of Nursing, published by Wolters Kluwer, which provides a rare glimpse of the realities clinicians and patients with Ebola faced inside one Ebola Treatment Unit.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 24-Nov-2015
Pre-travel advice does not reduce the risk of falling ill while traveling
Traveling abroad involves risk of illnesses and carriage of antibiotic resistant bacteria, especially among students. Illnesses such as travelers' diarrhea and respiratory tract infections are most common. Even if travelers follow the travel medicine clinics' advice on how to reduce risks during travel, the risk of falling ill is not reduced. This according to a dissertation at Umeå University in Sweden.

Contact: Daniel Harju
Umea University

Public Release: 24-Nov-2015
Millions of women severely undernourished in low- and middle-income countries
More than 18 million women in low- and middle-income countries around the world are severely undernourished, according to the first global estimate published in a new study from St. Michael's Hospital and Harvard T.H. Chan School of Public Health.

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 23-Nov-2015
ACC to establish PINNACLE Registry in Mexico
The American College of Cardiology will partner with the ACC Mexico Chapter, in collaboration with both the Sociedad Mexicana de Cardiología and the Asociación Nacional de Cardiólogos de México, to establish a registry network in Mexico that is aligned with the ACC's PINNACLE Registry.

Contact: Katie Glenn
American College of Cardiology

Public Release: 23-Nov-2015
Proceedings of the National Academy of Sciences
TSRI scientists reveal potential treatment for life-threatening viral infections
Scientists from the Florida campus of The Scripps Research Institute have shown for the first time how a previously unknown process works to promote infection in a number of dangerous viruses, including dengue, West Nile and Ebola.
National Institutes of Health

Contact: Eric Sauter
Scripps Research Institute

Public Release: 23-Nov-2015
Proceedings of the National Academy of Sciences
University of California scientists create malaria-blocking mosquitoes
Using a groundbreaking gene editing technique, University of California scientists have created a strain of mosquitoes capable of rapidly introducing malaria-blocking genes into a mosquito population through its progeny, ultimately eliminating the insects' ability to transmit the disease to humans. This new model represents a notable advance in the effort to establish an antimalarial mosquito population, which with further development could help eradicate a disease that sickens millions worldwide each year.
National Institutes of Health

Contact: Tom Vasich
University of California - Irvine

Public Release: 22-Nov-2015
International Journal of Epidemiology
UEA leads first systematic review of Ebola risks
Looking after people with late-stage Ebola at home puts people at greatest risk of catching it themselves -- according to research from the University of East Anglia.
National Institute for Health Research, Health Protection Research Unit in Emergency Preparedness and Response, Public Health England

Contact: Lisa Horton
University of East Anglia

Public Release: 20-Nov-2015
Arizona Regents recognize TGen with award for Outstanding Service to Higher Education
The Arizona Board of Regents presented the Translational Genomics Research Institute with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University.

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 19-Nov-2015
All in the family
Anthropologists study the Tsimane people of Bolivia to determine how parasitism affects female fertility.

Contact: Julie Cohen
University of California - Santa Barbara

Public Release: 19-Nov-2015
AIDS Research and Human Retroviruses
Progress toward preventing HIV highlighted in special issue of AIDS research and human retroviruses
New and emerging biomedical pre-exposure prophylaxis (PrEP) approaches to prevent HIV infection in targeted high-risk populations offer the most effective near-term strategy to reduce HIV transmission. The latest outcomes research, clinical trials results, and advances in HIV vaccine development are highlighted in multiple articles that comprise the annual HIV Prevention Science issue of AIDS Research and Human Retroviruses.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 19-Nov-2015
PLOS Pathogens
Monkeys in Asia harbor virus from humans, other species
When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause infectious gastroenteritis or diarrhea in humans. The study was published Nov. 5 in PLOS Pathogens.
National Science Foundation

Contact: Bobbi Nodell
University of Washington Health Sciences/UW Medicine

Public Release: 18-Nov-2015
NIH-led effort details global brain disorders research agenda in Nature supplement
The breadth and complexity of brain and nervous system disorders make them some of the most difficult conditions to diagnose and treat, especially in the developing world, where there are few resources. An NIH-led collaboration of more than 40 scientists has studied these complex issues that occur across the lifespan and today published a supplement to the journal Nature that lays out a research strategy to address them.

Contact: Ann Puderbaugh
NIH/Fogarty International Center

Public Release: 18-Nov-2015
Lancet Infectious Diseases
Study finds that Ebola vaccine is safe and stimulates strong immune response
A clinical trial of a new Ebola vaccine has found that it is well tolerated and stimulates strong immune responses in adults in Mali and in the US, according to a study published in the latest issue of the journal Lancet Infectious Diseases.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 18-Nov-2015
PLOS Pathogens
FDA-approved drug protects mice from Ebola
A new study suggests that gamma interferon, which is an FDA-approved drug, may have potential as an antiviral therapy to prevent Ebola infection when given either before or after exposure to the virus. The University of Iowa study, published Nov. 12 in the journal PLOS Pathogens, found that gamma interferon, given up to 24 hours after exposure, can inhibit Ebola infection in mice and completely protect the animals from death.

Contact: Jennifer Brown
University of Iowa Health Care

Showing releases 851-875 out of 1343.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 > >>